# DNA PAX1 and JAM3 Methylation for Cervical Cancer Screening

> **NCT05290428** · — · UNKNOWN · sponsor: **Peking Union Medical College Hospital** · enrollment: 459 (estimated)

## Conditions studied

- Cervical Cancer
- Cervical Intraepithelial Neoplasia
- DNA Methylation
- Cancer Screening
- Detection Accuracy

## Interventions

- **DIAGNOSTIC_TEST:** DNA methylation testing

## Key facts

- **NCT ID:** NCT05290428
- **Lead sponsor:** Peking Union Medical College Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-03-12
- **Primary completion:** 2022-09-12
- **Final completion:** 2022-12-12
- **Target enrollment:** 459 (ESTIMATED)
- **Last updated:** 2022-03-22

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05290428

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05290428, "DNA PAX1 and JAM3 Methylation for Cervical Cancer Screening". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05290428. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*